JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 16, 2003; DOI: 10.1124/jpet.103.055327


0022-3565/04/3081-339-349$20.00
JPET 308:339-349, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.055327v1
308/1/339    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffin, M. T.
Right arrow Articles by Ehlert, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffin, M. T.
Right arrow Articles by Ehlert, F. J.

CELLULAR AND MOLECULAR

Muscarinic Agonist-Mediated Heterologous Desensitization in Isolated Ileum Requires Activation of Both Muscarinic M2 and M3 Receptors

Michael T. Griffin, Minoru Matsui1, Darakhshanda Shehnaz2, Khurram Z. Ansari, Makoto M. Taketo3, Toshiya Manabe, and Frederick J. Ehlert

Department of Physical Sciences, Chapman University, Orange, California (M.T.G.); Laboratory of Biomedical Genetics, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan (M.M., M.M.T.); Department of Pharmacology, College of Medicine, University of California, Irvine, Irvine, California (D.S., K.Z.A., F.J.E.); and Division of Neural Network, Department of Basic Medical Sciences, University of Tokyo, Tokyo, Japan (T.M.)

We investigated the subtypes of the muscarinic receptor mediating short-term heterologous desensitization in the isolated ileum. Treatment of the ileum from C57BL/6 mice with acetylcholine (30 µM) for 20 min caused a subsequent decrease in contractile sensitivity to both prostaglandin F2{alpha} (PGF2{alpha}) and the muscarinic agonist, oxotremorine-M. This subsensitivity was characterized by 7- and 3-fold increases in the EC50 values of the agonists, respectively, with no significant effect on the maximal response. The subsensitivity to PGF2{alpha} was prevented in both M2 and M3 muscarinic receptor knockout mice. Similarly, the subsensitivity to oxotremorine-M was prevented in M2 knockout mice. Acetylcholine-mediated desensitization of histamine-induced contractions in the guinea pig ileum was inhibited by both M2- and M3-selective muscarinic antagonists with high potency, although careful analysis of the data suggested behavior more consistent with an M2 antagonistic profile. Modeling studies showed that the competitive antagonism of response contingent upon activation of two receptor subtypes should exhibit a pharmacological profile similar to that of the least sensitive signaling pathway. Our results demonstrate that muscarinic agonist-mediated short-term heterologous desensitization of intestinal smooth muscle is contingent upon activation of both M2 and M3 muscarinic receptors and that activation of either receptor by itself is insufficient to cause desensitization.


Received June 6, 2003; accepted August 22, 2003.

Address correspondence to: Dr. Frederick J. Ehlert, Department of Pharmacology, University of California, Irvine, Irvine, California 92697-4625. E-mail: fjehlert{at}uci.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. S. Braverman, A. S. Tibb, and M. R. Ruggieri Sr
M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. I. Normal Rat Bladder
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 869 - 874.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. J. Ehlert, M. T. Griffin, D. M. Abe, T. H. Vo, M. M. Taketo, T. Manabe, and M. Matsui
The M2 Muscarinic Receptor Mediates Contraction through Indirect Mechanisms in Mouse Urinary Bladder
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 368 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. J. Ehlert, J. C.-H. Hsu, K. Leung, A. G. Lee, D. Shehnaz, and M. T. Griffin
Comparison of the Antimuscarinic Action of p-Fluorohexahydrosiladifenidol in Ileal and Tracheal Smooth Muscle
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 592 - 600.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.